Skip to main content
AC

atDose Co., Ltd.

The startup has developed a mobile dosing and infusion device that utilizes a microneedle and an electroosmotic flow pump to deliver medication directly to targeted areas, similar to acupuncture and moxibustion techniques. This approach enables cancer patients to minimize the physical burden associated with the side effects of traditional drug therapies.

Yokohama, JapanFounded 2017350+ followers
Updated 3 months ago

Funding

$870K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional systemic drug administration methods often result in significant side effects due to the drug's impact on the entire body, rather than specifically targeting the affected area. This is particularly problematic in cancer treatment, where systemic chemotherapy can lead to adverse effects such as hair loss, nausea, and mucositis. Precise and localized drug delivery is needed to minimize these systemic toxicities.

Solution

atDose is developing a mobile micro-dosing and infusion device that enables precise, localized, and sustained drug delivery using an electroosmotic flow pump and microneedles. This technology allows for targeted administration of medications directly to the affected site, reducing the overall dosage required and minimizing systemic side effects. The electroosmotic pump allows for controlled micro-volume manipulation of viscous solutions through fine needles, enabling applications such as silicone oil removal during microincision vitrectomy surgery (MIVS). The device can be customized for various research applications, providing researchers with precise control over the timing, quantity, and speed of drug administration in in vivo and in vitro studies.

Target Audience

The primary target audience includes researchers, pharmaceutical companies, and medical professionals in fields such as oncology, ophthalmology, and regenerative medicine who require precise and localized drug delivery solutions.

Features

  • Electroosmotic flow pump technology for precise and controlled micro-dosing
  • Mobile and customizable device for localized drug delivery
  • Suitable for viscous solutions and fine needles, enabling applications in ophthalmology (MIVS) and oncology
  • Programmable control for periodic or sustained drug delivery
  • Potential for integration with sensors for feedback-controlled drug administration (IoMT)
This profile is AI-generated and may contain inaccuracies.